Viking Therapeutics (VKTX) Q2 2025 Earnings

23AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.41
-0.34
-0.27
-0.2

Details

Expected EPS
-0.328002
Actual EPS
-0.41
Surprise EPS
-0.08
Surprise Percent
+25%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.41 per share for Q2 2025.

0 Comments

Share your thoughts